bluebird bio Inc banner

bluebird bio Inc
NASDAQ:BLUE

Watchlist Manager
bluebird bio Inc Logo
bluebird bio Inc
NASDAQ:BLUE
Watchlist
Price: 4.97 USD Market Closed
Market Cap: $48.7m

Balance Sheet

Balance Sheet Decomposition
bluebird bio Inc

Balance Sheet
bluebird bio Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
26
67
206
348
164
279
759
403
327
318
161
113
222
62
Cash Equivalents
26
67
206
348
164
279
759
403
327
318
161
113
222
62
Short-Term Investments
4
0
0
126
354
426
532
983
779
834
138
67
0
0
Total Receivables
0
0
0
0
0
0
3
0
0
0
0
0
0
3
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
23
65
Other Current Assets
1
1
6
6
6
20
30
34
45
64
37
19
37
24
Total Current Assets
30
68
212
480
524
724
1 323
1 419
1 152
1 216
337
200
282
155
PP&E Net
1
1
11
16
83
157
200
247
337
347
101
291
267
238
PP&E Gross
1
1
11
16
83
157
200
247
337
347
101
291
267
238
Accumulated Depreciation
1
1
2
3
7
12
16
29
37
51
20
22
42
103
Intangible Assets
0
0
0
28
25
21
17
13
14
10
0
5
10
10
Goodwill
0
0
0
13
13
13
13
13
13
13
6
6
6
6
Long-Term Investments
0
0
0
18
348
181
324
506
132
123
97
1
0
0
Other Long-Term Assets
0
0
2
1
10
23
24
45
79
73
53
52
54
53
Other Assets
0
0
0
13
13
13
13
13
13
13
6
6
6
6
Total Assets
31
N/A
69
+124%
224
+224%
557
+148%
1 002
+80%
1 118
+12%
1 901
+70%
2 243
+18%
1 727
-23%
1 781
+3%
594
-67%
555
-7%
619
+12%
460
-26%
Liabilities
Accounts Payable
2
2
4
3
6
14
13
18
43
22
26
25
18
34
Accrued Liabilities
1
2
4
13
23
50
55
97
136
150
124
101
89
108
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
1
1
0
0
0
0
85
160
Other Current Liabilities
0
0
26
27
11
11
27
31
44
32
3
2
8
19
Total Current Liabilities
3
5
35
43
40
75
96
146
224
204
153
128
200
321
Long-Term Debt
0
0
0
0
62
120
155
153
0
0
0
0
38
8
Deferred Income Tax
0
0
1
2
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
1
37
21
50
54
27
58
219
223
67
230
187
163
Total Liabilities
4
N/A
5
+24%
73
+1 298%
66
-10%
152
+132%
249
+64%
277
+11%
358
+29%
442
+24%
426
-4%
220
-48%
359
+63%
425
+18%
492
+16%
Equity
Common Stock
82
122
0
0
0
0
1
1
1
1
1
1
2
2
Retained Earnings
63
73
99
147
314
578
914
1 499
2 282
2 901
3 720
3 987
4 260
4 501
Additional Paid In Capital
8
15
250
638
1 167
1 448
2 541
3 387
3 568
4 260
4 096
4 186
4 455
4 470
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
2
1
4
4
2
6
3
4
2
2
Total Equity
27
N/A
64
+140%
152
+137%
491
+224%
851
+73%
869
+2%
1 623
+87%
1 885
+16%
1 285
-32%
1 355
+5%
374
-72%
196
-48%
195
-1%
32
N/A
Total Liabilities & Equity
31
N/A
69
+124%
224
+224%
557
+148%
1 002
+80%
1 118
+12%
1 901
+70%
2 243
+18%
1 727
-23%
1 781
+3%
594
-67%
555
-7%
619
+12%
460
-26%
Shares Outstanding
Common Shares Outstanding
0
0
1
2
2
2
2
3
3
3
4
4
10
10
Preferred Shares Outstanding
190
311
0
0
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett